Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Comments

Loading...

Coherus BioSciences Stock News

CHRSNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$0.8215

0.045.08%

At close: -

$0.8215

0.000.00%

After Hours: 4:00 PM EDT

Coherus BioSciences (CHRS) Forecast

News

Earnings Coherus BioSciences (CHRS) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Latest Coherus BioSciences Stock News | NASDAQ:CHRS | Benzinga

Get the latest news on Coherus BioSciences stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Coherus BioSciences performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Tuesday, April 01, 2025

Coherus Announces Repurchase Of ~$170M Of Con...
Benzinga Newsdesk - 6 days ago

Tuesday, March 25, 2025

Coherus To Present Data From Phase 1 Dose Exp...
Benzinga Newsdesk - Mar 25, 2025, 4:31PM

Tuesday, March 11, 2025

HC Wainwright & Co. Reiterates Buy on Coherus...
Benzinga Newsdesk - Mar 11, 2025, 6:27AM

Monday, March 10, 2025

Coherus Biosciences Projects Post-UDENYCA-Clo...
Benzinga Newsdesk - Mar 10, 2025, 4:15PM
Coherus BioSciences Q4 2024 Adj. EPS $(0.28) ...
Benzinga Newsdesk - Mar 10, 2025, 4:14PM
Earnings Scheduled For March 10, 2025
Benzinga Insights - Mar 10, 2025, 4:32AM

Thursday, January 23, 2025

Coherus Biosciences Awarded $27,626,788.30 Co...
Benzinga Newsdesk - Jan 23, 2025, 3:40PM
HC Wainwright & Co. Reiterates Buy on Coherus...
Benzinga Newsdesk - Jan 23, 2025, 6:58AM

Wednesday, January 22, 2025

Coherus Biosciences Announced Final Data From...
Benzinga Newsdesk - Jan 22, 2025, 7:12AM

Monday, January 13, 2025

Coherus Biosciences Sees FY24 Prelim. Net Rev...
Benzinga Newsdesk - Jan 13, 2025, 4:30PM

Wednesday, December 18, 2024

Coherus To Present Randomized Phase 2 Study E...
Benzinga Newsdesk - Dec 18, 2024, 8:45AM

Thursday, December 05, 2024

Baird Maintains Outperform on Coherus BioScie...
Benzinga Newsdesk - Dec 5, 2024, 8:13AM

Wednesday, December 04, 2024

HC Wainwright & Co. Reiterates Buy on Coherus...
Benzinga Newsdesk - Dec 4, 2024, 6:37AM

Tuesday, December 03, 2024

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights - Dec 3, 2024, 4:05PM
Why Is Coherus BioSciences Stock Trading Higher On Tuesday?
Vandana Singh - Dec 3, 2024, 9:34AM
Coherus Biosciences shares are trading higher...
Benzinga Newsdesk - Dec 3, 2024, 8:20AM
Coherus Biosciences Has Agreed To Divest Uden...
Benzinga Newsdesk - Dec 3, 2024, 7:08AM

Friday, November 08, 2024

Baird Maintains Outperform on Coherus BioScie...
Benzinga Newsdesk - Nov 8, 2024, 7:27AM

Thursday, November 07, 2024

Coherus BioSciences shares are trading higher...
Benzinga Newsdesk - Nov 7, 2024, 12:20PM
Reported November 6: Coherus BioSciences Q3 2...
Benzinga Newsdesk - Nov 7, 2024, 12:18PM
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights - Nov 7, 2024, 11:31AM
HC Wainwright & Co. Reiterates Buy on Coherus...
Benzinga Newsdesk - Nov 7, 2024, 6:23AM

Monday, September 16, 2024

HC Wainwright & Co. Reiterates Buy on Coherus...
Benzinga Newsdesk - Sep 16, 2024, 7:57AM

Friday, August 16, 2024

Coherus Biosciences shares are trading lower ...
Benzinga Newsdesk - Aug 16, 2024, 12:07PM
UBS Downgrades Coherus BioSciences to Neutral...
Benzinga Newsdesk - Aug 16, 2024, 7:31AM

Thursday, August 08, 2024

Coherus BioSciences shares are trading higher...
Benzinga Newsdesk - Aug 8, 2024, 5:19PM
Coherus BioSciences Sees FY24 R&D And SG&A Ex...
Benzinga Newsdesk - Aug 8, 2024, 5:10PM
Coherus BioSciences Q2 2024 Adj. EPS $(0.14) ...
Benzinga Newsdesk - Aug 8, 2024, 4:21PM

Monday, August 05, 2024

HC Wainwright & Co. Reiterates Buy on Coherus...
Benzinga Newsdesk - Aug 5, 2024, 6:51AM

Monday, July 01, 2024

Baird Maintains Outperform on Coherus BioScie...
Benzinga Newsdesk - Jul 1, 2024, 7:20AM

Thursday, June 27, 2024

Coherus BioSciences To Divest YUSIMRY In $40M...
Benzinga Newsdesk - Jun 27, 2024, 8:28AM

Friday, May 24, 2024

HC Wainwright & Co. Reiterates Buy on Coherus...
Benzinga Newsdesk - May 24, 2024, 6:26AM

Monday, May 13, 2024

Truist Securities Maintains Buy on Coherus Bi...
Benzinga Newsdesk - May 13, 2024, 8:19AM

Friday, May 10, 2024

HC Wainwright & Co. Maintains Buy on Coherus ...
Benzinga Newsdesk - May 10, 2024, 3:37PM
Coherus BioSciences shares are trading lower ...
Benzinga Newsdesk - May 10, 2024, 12:28PM

Thursday, May 09, 2024

Coherus BioSciences Q1 2024 Adj EPS $(0.32) M...
Benzinga Newsdesk - May 9, 2024, 5:15PM
Coherus Announces Full Repayment of Pharmakon...
Benzinga Newsdesk - May 9, 2024, 8:46AM

Wednesday, May 08, 2024

Coherus To Collaborate With Cancer Research I...
Benzinga Newsdesk - May 8, 2024, 9:01AM

Monday, April 08, 2024

Coherus Presents Preclinical Data For CHS-100...
Benzinga Newsdesk - Apr 8, 2024, 8:34AM

Wednesday, March 20, 2024

HC Wainwright & Co. Maintains Buy on Coherus ...
Benzinga Newsdesk - Mar 20, 2024, 7:19AM

Thursday, March 14, 2024

HC Wainwright & Co. Reiterates Buy on Coherus...
Benzinga Newsdesk - Mar 14, 2024, 7:33AM

Wednesday, March 13, 2024

Coherus BioSciences shares are trading lower ...
Benzinga Newsdesk - Mar 13, 2024, 4:34PM
Coherus BioSciences Sees FY24 R&D And SG&A Ex...
Benzinga Newsdesk - Mar 13, 2024, 4:25PM
Recap: Coherus BioSciences Q4 Earnings
Benzinga Insights - Mar 13, 2024, 4:05PM
Coherus BioSciences Q4 2023 Adj EPS $(0.62) M...
Benzinga Newsdesk - Mar 13, 2024, 4:03PM
Earnings Scheduled For March 13, 2024
Benzinga Insights - Mar 13, 2024, 6:15AM

Tuesday, March 12, 2024

Earnings Preview For Coherus BioSciences
Benzinga Insights - Mar 12, 2024, 12:00PM

Wednesday, February 21, 2024

Coherus Launches UDENYCA ONBODY For Pegfilgra...
Benzinga Newsdesk - Feb 21, 2024, 8:31AM

Tuesday, January 23, 2024

Baird Maintains Outperform on Coherus BioScie...
Benzinga Newsdesk - Jan 23, 2024, 3:05PM
Truist Securities Maintains Buy on Coherus Bi...
Benzinga Newsdesk - Jan 23, 2024, 7:53AM

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved